In POMGnT1-knockout human retinal pigment epithelial cells, ATP concentrations after 40 µM RIPA-56 treatment were 103.7 ± 6.1% of wild-type levels. In organotypic hippocampal slice cultures from male rats, the lower NO release observed with TNFα + IFNγ + I19 compared with TNFα + IFNγ was not observed with RIPA-56. In POMGnT1-/- RPE cells, 40 µM RIPA-56 for 24 h significantly reduced phosphorylation of RIP1, RIP3, and MLKL. [1,2]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
ATP concentrations in POMGnT1-knockout retinal pigment epithelial cells
Cell-based study · POMGnT1-knockout (KO) human retinal pigment epithelial (hRPE) cells [1]
POMGnT1-knockout human retinal pigment epithelial cells were treated with 40 µM RIPA-56. ATP concentrations after treatment were 103.7 ± 6.1% of wild-type levels.
Literature-Reported Treatment Conditions
- Treatment concentration
- 40 µM
- Vehicle
- DMSO
- Reported limits
- Not stated in the sentences used: route, schedule.
Methods and source locations
Compound reported in the paper: RIPA-56
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > AAV8-hPOMGnT1 and RIPA-56 rescue ATP production in POMGnT1-knockout hRPE cells (S156, S157, S158, S159); Materials and Methods > Cell culture (S233)
ATP concentrations were quantified and expressed as a percentage of wild-type levels: ATP concentrations were quantified and expressed as a percentage of wild-type levels; comparator: KO controls — Results > AAV8-hPOMGnT1 and RIPA-56 rescue ATP production in POMGnT1-knockout hRPE cells (S156, S157, S159)
Nitrite content in organotypic hippocampal slice cultures from male rats
Cell-based study · organotypic hippocampal slice cultures from male rats [2]
Model: organotypic hippocampal slice cultures from male rats. Treatment: 100 µM. Result: RIPA-56 (R56, 100 µM when alone): NO release was lower in slice cultures exposed to TNFα + IFNγ + I19 compared with TNFα + IFNγ, an effect not observed for R56..
Literature-Reported Treatment Conditions
- Treatment concentration
- 100 µM
- Exposure duration
- for 72 h with or without simultaneous exposure
- Method
- added to the medium
- Co-treatment
- Other interventions in this design: TNF-α 100 ng/mL; IFN-γ 100 ng/mL. Compound effect isolated by the comparison: TNFα + IFNγ.
- Reported limits
- Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: RIPA-56
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and methods > Exposures and microglial ablation (S15); Materials and methods > Biochemical assays (S30); Results (S168); Results > Inhibition of TNFR1 signaling protects neural gamma oscillations (S313, S317, S328)
Nitrite content: Nitrite content; comparator: TNFα + IFNγ — Results > Inhibition of TNFR1 signaling protects neural gamma oscillations (S313, S317, S328)
Phosphorylation changes in POMGnT1-knockout retinal pigment epithelial cells
Cell-based study · POMGnT1-/- RPE cells [1]
POMGnT1-/- RPE cells were treated with 40 µM RIPA-56 for 24 h. Treatment significantly reduced phosphorylation of RIP1, RIP3, and MLKL.
Literature-Reported Treatment Conditions
- Treatment concentration
- 40 µM
- Exposure duration
- 24 h
- Vehicle
- DMSO
- Reported limits
- Not stated in the sentences used: route.
Methods and source locations
Compound reported in the paper: RIPA-56
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > RIPA-56 attenuates necroptosis-induced cell death and restores paracellular permeability in human retinal pigment epithelial (RPE) cells by targeting the RIP1 pathway (S110, S112, S114, S122); Materials and Methods > Cell culture (S233)
phosphorylation of RIP1, RIP3, and MLKL: phosphorylation of RIP1, RIP3, and MLKL; comparator: POMGnT1 knockout (POMGnT1-/-) — Results > RIPA-56 attenuates necroptosis-induced cell death and restores paracellular permeability in human retinal pigment epithelial (RPE) cells by targeting the RIP1 pathway (S114, S122)